npj Breast Cancer (Mar 2025)

Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial

  • Ioannis Zerdes,
  • Alexios Matikas,
  • Artur Mezheyeuski,
  • Georgios Manikis,
  • Balazs Acs,
  • Hemming Johansson,
  • Ceren Boyaci,
  • Caroline Boman,
  • Coralie Poncet,
  • Michail Ignatiadis,
  • Yalai Bai,
  • David L. Rimm,
  • David Cameron,
  • Hervé Bonnefoi,
  • Jonas Bergh,
  • Gaetan MacGrogan,
  • Theodoros Foukakis

DOI
https://doi.org/10.1038/s41523-025-00730-1
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Breast cancer (BC) represents a heterogeneous ecosystem and elucidation of tumor microenvironment components remains essential. Our study aimed to depict the composition and prognostic correlates of immune infiltrate in early BC, at a multiplex and spatial resolution. Pretreatment tumor biopsies from patients enrolled in the EORTC 10994/BIG 1-00 randomized phase III neoadjuvant trial (NCT00017095) were used; the CNN11 classifier for H&E-based digital TILs (dTILs) quantification and multiplex immunofluorescence were applied, coupled with machine learning (ML)-based spatial features. dTILs were higher in the triple-negative (TN) subtype, and associated with pathological complete response (pCR) in the whole cohort. Total CD4+ and intra-tumoral CD8+ T-cells expression was associated with pCR. Higher immune-tumor cell colocalization was observed in TN tumors of patients achieving pCR. Immune cell subsets were enriched in TP53-mutated tumors. Our results indicate the feasibility of ML-based algorithms for immune infiltrate characterization and the prognostic implications of its abundance and tumor-host interactions.